// App-Quantinova.ai

2179 : Mutation Profiles Identify Distinct Clusters of Lower Risk Myelodysplastic Syndromes with Unique Clinical and Biological Features and Clinical Endpoints

Researchers

Presenter

  • Luca Malcovati

Principal Investigators

  • Aniek O. De Graaf

  • Sarah Sandmann

  • Magnus Tobiasson

  • Olivier Kosmider

  • Bert A. van der Reijden

  • Daniel Painter

  • Arjan A. Van de Loosdrecht

  • Argiris Symeonidis

  • Jaroslav Cermak

  • Emmanuelle Clappier

  • Claude Preudhomme

  • Reinhard Stauder

  • Moshe Mittelman

  • Ulrich Germing

  • David Bowen

  • Pierre Fenaux

  • Corine Van Marrewijk

  • Alexandra Smith

  • Martin Dugas

  • Eva Hellstrom Lindberg

  • Theo M de Witte

  • Michaela Fontenay

  • Joop Jansen

Medical Centers

  • Department of Hematology Oncology & Molecular Medicine, University of Pavia Medical School, Piazzale Golgi, Italy

  • Departments of Molecular Medicine & Hematology Oncology, University of Pavia & Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

  • Epidemiology&Genetics Unit, Department of Health Sciences, University of York, York, United Kingdom

  • Experimental Rheumatology, Radboud university medical center, Nijmegen, The Netherlands, Nijmegen, Netherlands

  • Muenster University, Muenster, DEU

  • Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska University Hospital Huddinge, Karolinska Institute, Stockholm, Sweden

  • Assistance Publique Hôpitaux de Paris, Laboratoire d'hématologie, Hôpital Cochin, APHP Laboratoire d'Hématologie, Hôpital Cochin, Paris, France

  • Laboratory Medicine-Laboratory of Hematology, Radboud University Medical Center, Nijmegen, Netherlands

  • Epidemiology and Cancer Statistics Group, University of York, York, United Kingdom

  • Department of radiology, LUMC, Leiden, Netherlands

  • Hematology Division, Department of Internal Medicine, University of Patras Medical School, Patras, Greece

  • Institute of Hematology and Blood Transfusion, Prague, Czech Republic

  • Hôpital Robert Debré, AP-HP, Paris, FRA

  • Centre de Biologie-Pathologie du CHRU de Lille, Lille, France

  • Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University (IMU), Innsbruck, Innsbruck, Austria

  • Tel Aviv Sourasky Medical Center and Sakler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

  • Department of Hematology, Oncology and Clinical Immunology, Universitaetsklinikum Duesseldorf, Duesseldorf, Germany,

  • Paediatric Haematology,Leeds Teaching Hospitals,Leeds,United Kingdom

  • Hospital Saint Antoine, Paris, France

  • Department of Urology, Radboud University Medical Center, Nijmegen, Netherlands

  • Epidemiology and Cancer Statistics Group, Department of Health Sciences,University of York,York,United Kingdom

  • Institute of Medical Informatics, University of Muenster, Muenster, Germany

  • HERM, Dept. of Medicine, Huddinge, Karolinska Institute, and PO Hematology,Karolinska University Hospital,Stockholm,Sweden

  • Dep. of Tumor Immunology - Nijmegen Center for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, Netherlands

  • Laboratoire d'Hématologie, Hôpital Cochin, Paris, FRA

  • Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, Netherlands

Locations

  • Italy

  • United Kingdom

  • Netherlands

  • Sweden

  • France

  • Greece

  • Czech Republic

  • Austria

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Myelodysplastic Syndrome

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved